Login / Signup

Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis.

Joel Adu-BrimpongJennifer PughDavid Agyen DarkoLisa Shieh
Published in: Journal of medical Internet research (2023)
Our findings indicate opportunities for improved sociodemographic representation in DTx clinical trials, especially for underserved populations typically underrepresented in clinical trials. This review is a step in examining sociodemographic representation in DTx clinical trials to help inform the path forward for DTx development and testing.
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • double blind
  • phase iii
  • small molecule
  • randomized controlled trial
  • cross sectional